FAS and neoplasm: The fact that there was no variation in mRNAs for Fas and Fas L, and neither for any other death receptors or ligands (Figure 5B) indicates that this indolamine does not regulate such death proteins in a general manner, but it does so very specifically in some tumour cells, where it is able to induce cell death.